Company: SHPH
Filing Date: 2025-01-24
Form Type: 424B3
Source: 0001493152-25-003508
Chunk: 143

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-24
Form: 424B3
Chunk 143
---
 |   |     | Option Exercise Price ($) |   |     | Option Expiration Date |   |     | Stock Awards                       
 Number of Shares or Units of Stock 
 not yet Vested (#))                |        |     | Market Value of Shares or Units 
 not yet Vested ($)              |        |
|:----------------|:----|:--------------|:----|:------------------------------------|:--|:----|:--------------------------------------|:--|:----|:--------------------------|:--|:----|:-----------------------|:--|:----|:-----------------------------------|-------:|:----|:--------------------------------|-------:|
| Mira Jung1      |     | 5/1/23        |     |                                     | - |     |                                       | - |     |                           | - |     |                        | - |     |                                    |  1,194 |     | $                               |  1,026 |
| Timothy Lorber2 |     | 6/13/24       |     |                                     | - |     |                                       | - |     |                           | - |     |                        | - |     |                                    | 28,455 |     | $                               | 24,443 |

| (1) | These                                                                                 
 restricted stock units vest in two installments on the anniversary of the grant date. |
| (2) | These restricted stock units vest in three installments                               
 on the anniversary of the grant date.                                                 |

2018 Equity Incentive Plan

Our 2018 Equity Incentive Plan provides for equity incentives to be granted to our employees, executive officers or directors and to key advisers and consultants. Equity incentives may be in the form of stock options with an exercise price of not less than the fair market value of the underlying shares as determined pursuant to the 2018 Equity Incentive Plan, restricted stock awards, other stock- based awards, or any combination of the foregoing. The 2018 Equity Incentive Plan is administered by the Company’s compensation committee or, alternatively, if there is no compensation committee, the Company’s board of directors. We have reserved 3,000,000 shares of our common stock for issuance under the Plan, of which 1,187,189 shares have been granted under the Plan as of the date of this registration statement.

Director Compensation

Each of our non-employee directors, pursuant to the terms of director agreements (the “Director Agreements”), between each of the directors and the Company, receives